Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

ARTEMIS TECHNOLOGIES INC

UEI: HKZ8PU9ZUE22CAGE: L0AS7

ARTEMIS TECHNOLOGIES INC is a federal contractor, registered under UEI HKZ8PU9ZUE22 and CAGE code L0AS7. It has been awarded $26,826,114 in federal contracts. Primary work spans Biological Product (except Diagnostic) Manufacturing. Top awarding agencies include Department Of Agriculture.

Contact Information

Registration and classification details

Registration

UEI Code

HKZ8PU9ZUE22

CAGE Code

L0AS7

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationForeign OwnedManufacturer of Goods

NAICS Codes

325414Biological Product (except Diagnostic) Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ARTEMIS TECHNOLOGIES INC specializes in the manufacturing of biological products for wildlife disease control, with a focused expertise in oral rabies vaccine baits. The company designs, develops, and produces regulated biological formulations tailored for environmental deployment, ensuring precise ...

ARTEMIS TECHNOLOGIES INC specializes in the manufacturing of biological products for wildlife disease control, with a focused expertise in oral rabies vaccine baits. The company designs, develops, and produces regulated biological formulations tailored for environmental deployment, ensuring precise vaccine delivery to target wildlife populations. Their technical capabilities encompass lyophilized vaccine stabilization, bait matrix engineering, and compliance with biosafety and wildlife application standards. ARTEMIS demonstrates deep proficiency in handling live viral vectors under controlled manufacturing conditions, adhering to strict biocontainment protocols and quality assurance frameworks required for veterinary biologics. Their ability to scale production of environmentally safe, palatable bait systems for widespread aerial and ground distribution sets them apart as a specialized provider in wildlife health intervention. The contractor maintains a consistent and exclusive relationship with the U.S. Department of Agriculture, delivering mission-critical oral rabies vaccination programs that support national zoonotic disease prevention efforts. Their work directly supports USDA’s Animal and Plant Health Inspection Service (APHIS) initiatives to contain rabies in raccoon, fox, and skunk populations across North American wildlife corridors. This sustained engagement reflects a trusted partnership rooted in reliable delivery of complex biological countermeasures under evolving field deployment requirements. ARTEMIS operates within NAICS 325414, the category for biological product manufacturing excluding diagnostics, placing them squarely in the veterinary biologics and wildlife health sector. They are a niche provider focused exclusively on live-virus vaccine formulation and environmental delivery systems, serving a highly regulated segment of the federal biosecurity market. As a 2L entity headquartered in Guelph, Ontario, ARTEMIS TECHNOLOGIES INC operates as a mid-sized manufacturer with no public certifications on record. Their geographic positioning supports cross-border collaboration with U.S. federal agencies, leveraging proximity to key wildlife management zones and regulatory pathways governing transboundary biological product distribution.

Key Performance Metrics

Awards Count

30

All time

Active

0

Currently performing

Completed

30

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with ARTEMIS TECHNOLOGIES INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for ARTEMIS TECHNOLOGIES INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in ARTEMIS TECHNOLOGIES INC's top NAICS codes and agencies

NAICS: 325414
DIBBS
JAPANESE ENCEPHALIT
Solicitation # SPE2DP-26-R-0001
The Defense Logistics Agency Troop Support is soliciting Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringes under solicitation SPE2DP-26-R-0001, with a sole source justification under FAR 6.302-1 due to the unique nature of the product and regulatory requirements. The acquisition will follow Part 12 procedures for commercial items, resulting in a firm-fixed-price, indefinite delivery, indefinite quantity contract with an 18-month base term. The minimum order is 277,760 units, with an estimated and maximum quantity of 277,760 and 394,240 units respectively. Vaccines must be FDA-approved prior to the solicitation’s closing date and must comply with MPID Number 5 dated July 23, 2024. All deliveries are FOB destination to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, with a 120-day production lead time following issuance of each DD1155 delivery order. Inspection and acceptance occur at the delivery point, and the contractor is responsible for certification of conformity with all specifications including FDA regulations and labeling requirements. All packaging, marking, and labeling must adhere to strict government standards including MIL-STD-2073-1 for preservation, MIL-STD-129 for shipping labels, and MIL-STD-130 for item identification. Units must be marked with the NSN, CAGE code, part number, contract number, preservation method and date, and transaction control number, with commercial preservation denoted as “COMM’L” and military as “M” followed by the method and date. Intermediate and exterior containers require bar codes compliant with DoD logistics standards, and hazardous materials necessitate a Shipper’s Declaration for Dangerous Goods and Safety Data Sheets. Shelf life must include at least 12 months remaining at time of delivery for Type I items, with expiration and manufacture dates clearly marked. Each shipment must include a destination label addressed to DODAAC SV3100, and all documentation must be in English using durable, legible markings. The contract requires electronic submission via the DIBBS portal and prohibits paper solicitations. Contractors must maintain inspection records for three years post-delivery and comply with all applicable federal regulations including the Federal Food, Drug, and Cosmetic Act and 49 CFR for hazardous materials. No socioeconomic set-asides apply,
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

7 days ago

DEADLINE

in 24 days
View Details
NAICS: 531120
Federal
Office space in the Milwaukee, WI area
Solicitation # 12314427MILWA
The U.S. Department of Agriculture Forest Service is seeking expressions of interest for the short-term rental of approximately 30,000 square feet of office space in the Milwaukee, Wisconsin area, with an anticipated acquisition date of April 1, 2026. The preferred location is within a specific delineated area of downtown Milwaukee, though the agency will consider properties in Milwaukee and Waukesha Counties if they offer better utility or cost savings. To be eligible for future solicitations, lessors must be registered in SAM.gov. The required facility must accommodate 81 cubicles and 18 private offices, including at least three with locking solid wood core doors. Essential amenities include one large conference room for 20 people, two small conference rooms for 10 people, a break area with a sink, and mail, copy, and supply rooms. Specialized requirements include 5,000 square feet of storage, specifically featuring 100 square feet for Li-ion batteries and 350 square feet of secured space with both interior and exterior access. Additionally, the space must provide secure parking for six vehicles and a server/IT room equipped for video conferencing and digital technologies. Optional features include shower facilities and private telephone booths. Interested parties must submit the property address, description, square footage, parking availability, and photographs to Craig Harper by October 14, 2026.
Department Of Agriculture

POSTED

12 days ago

DEADLINE

in 1 day
View Details
NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

13 days ago

DEADLINE

in 28 days
View Details
NAICS: 325414
DIBBS
MEDICAL PHARMACY EMERGENCY NON NSN ORDER
Solicitation # SPE2DP-26-R-0002
Solicitation SPE2DP-26-R-0002 is a federal request for a firm-fixed price, indefinite-delivery, indefinite-quantity contract to establish a source of supply for the Influenza Virus Vaccine, Southern Hemisphere 2027 Formula. The contract, issued by the Medical Supply Chain Pharmacy FSA for the Department of Defense, covers a twelve month term for quadrivalent or trivalent vaccines suitable for individuals aged six months and older. The required product consists of 0.5 ML doses provided in packages of ten syringes. All quantities must be delivered to the Defense Distribution Center in Susquehanna, Pennsylvania, by March 31, 2027, with delivery appointments coordinated through DLA Distribution Susquehanna. Proposals must be submitted exclusively via the DLA Internet Bid Board System by October 14, 2026. Evaluation is based on price and the ability to meet all solicitation terms, including the provision of FDA approval for manufacturers or a manufacturer's Letter of Commitment for dealers. The contractor is responsible for ensuring products comply with USP requirements and the Drug Supply Chain Security Act. Strict packaging and marking standards apply, specifically Medical Marking Standard No. 1D, with rigorous cold chain requirements for refrigerated items (2 to 8 degrees Celsius) and frozen items (-25 to -10 degrees Celsius), including the use of DLA-compatible temperature monitors. Invoicing and payment will be processed electronically through the Wide Area Workflow system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

15 days ago

DEADLINE

in about 16 hours
View Details